CIK 0001455365 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
COGNITION THERAPEUTICS INC
Sign in to watch- Ticker
- CGTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 412-481-2210
- Business address
- 2500 WESTCHESTER AVE, PURCHASE, NY, 10577
- Former names
- COGNITION THERAPUTICS INC
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Other events
- 8-K Event Regulation FD disclosure
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Results of operations
- 8-K Event Other events
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Other events
- 4 Grant or award Chief Medical Officer acquired 94,406 shares (grant or award)
- 4 Grant or award CEO & President acquired 213,973 shares (grant or award)
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 8-K Event Material agreement
- S-3 Offering Registration Statement
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 10,000 shares at $2.66 ($26,550)
- 4 Open-market buy Director bought 16,064 shares at $2.65 ($42,565)
- 4 Open-market buy Director bought 16,064 shares at $2.65 ($42,565)
Page 9 of 16 · 303 filings